Indira IVF, a network of infertility treatment hospitals in India, has ventured abroad with a hospital in Kathmandu, Nepal.  

This move comes after global private equity firm EQT became the majority owner of Indira IVF last year July.  

Indira IVF aims to establish five more clinics in Nepal.  

Indira IVF's medical facilities in India claim to have treated more than 400 patients from Nepal, Bangladesh, and Sri Lanka seeking infertility treatment. 

The company's CEO and co-founder Dr Kshitiz Murdia said: “Nepal has witnessed a consistent decline in fertility rates, reaching a low of 1.799 births per woman in 2023, in contrast to India’s 2.0 births per woman reported for 2019-21.  

“As the first organised assisted reproductive technology (ART) player from India entering the country, Indira IVF plans to establish five more clinics nationwide to address the growing demand and provide accessible fertility solutions to families.  

“Much like our approach in India, we aim to be trusted partners for all families seeking to fulfil their parenthood dreams.” 

Indira IVF plans to extend its expertise to South-East Asian, Middle-Eastern, European, and African countries. 

To ensure standardisation across its global operations, all specialists and staff members worldwide will undergo training on the latest technology, procedures, and standard processes at the Indira Fertility Academy (IFA), the academic wing of Indira IVF. 

It has a workforce exceeding 2,700 professionals spread across in more than 120 hospitals. 

Indira IVF managing director and co-founder Nitiz Murdia said: “Our vision and mission is eradicating infertility, and as a natural progression, we are actively exploring global markets to expand our services.  

“We have a meticulously structured international expansion strategy in place, with the aim of becoming the leader in every country we enter.  

“Recognising the multifaceted impact of infertility on families, including emotional, financial, and social aspects, we are committed to providing comprehensive solutions that address these challenges.”